Delivery Order SPE2DB22D3004-SPE2DB24FRV02
Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp for the supply of 60 tablets of 50 mg Naltrexone. The award, valued at $2,374.86, has a firm fixed price and an ultimate completion date of September 18, 2024. AmerisourceBergen, a for-profit pharmaceutical distributor, holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of prescription medications, medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60-count Naltrexone 50 mg tablets. The contract has a ceiling value of $5,187.32 and an ultimate completion date of August 16, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Naltrexone 50 mg tablets in 90-count packages, with a ceiling value of $7,106.19 and a performance period through March 13, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a $25,259.33 firm fixed-price delivery order for the supply of Naltrexone 50 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has an ultimate completion date of August 2, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical and medical products....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 60 count bottles of 50 mg Naltrexone tablets. The contract has a ceiling value of $5,229.03 and an ultimate completion date of August 5, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded multiple Indefinite Delivery Contracts (IDCs) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of 90 units of Naltrexone 50 mg tablets, with a potential value of $2,183.72 and a completion date of January 25, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has received numerous federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,658.62, is for the delivery of 60 count bottles of 50 mg Naltrexone tablets. Naltrexone is a medication used for the treatment of opioid and alcohol dependence. The contract is a firm fixed-price delivery order with an ultimate completion date of December 16, 2024. It is not designated as a set-aside contract....
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp in the amount of $4,768.43. The order is for 4565427144 - Naltrexone 50 MG Tablet 60s, which are pharmaceutical products used to treat opioid dependence. The delivery order falls under the DLA's Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999, that provides a range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units, with a ceiling value of $12,745.23. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 60-count bottles of Naltrexone 50 mg tablets. The contract has a ceiling value of $2,770.67 and a completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside. The contract is a firm-fixed-price delivery order, meaning AmerisourceBergen will provide the...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FRV02Delivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Naltrexone 50 mg tablets. The order, valued at $2,078.94, is a firm fixed-price contract with a completion date of September 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of medical commodities, including prescription drugs and supplies, to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives. This particular delivery order is not associated with a set-aside program.
Generated 12/12/24, 9:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/12/24 |